Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Scilex Holding (SCLX) Other Operating Expenses (2020 - 2025)

Scilex Holding has reported Other Operating Expenses over the past 6 years, most recently at -$16.9 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses changed N/A to -$16.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.4 million, a 260.94% decrease, with the full-year FY2025 number at -$12.2 million, changed N/A from a year prior.
  • Other Operating Expenses reached -$16.9 million in Q4 2025 per SCLX's latest filing, down from $4.7 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $5.5 million in Q4 2023, with the low at -$16.9 million in Q4 2025.
  • The 5-year median for Other Operating Expenses is $2.7 million (2022), against an average of $1.6 million.
  • The largest YoY upside for Other Operating Expenses was 29780.18% in 2021 against a maximum downside of 135731.54% in 2021.
  • Tracing SCLX's Other Operating Expenses over 5 years: stood at $1.5 million in 2021, then surged by 265.0% to $5.5 million in 2022, then grew by 0.14% to $5.5 million in 2023, then dropped by 2.81% to $5.4 million in 2024, then plummeted by 413.15% to -$16.9 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at -$16.9 million, $4.7 million, and $4.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.